Scar News and Research

RSS

Avita's ReCell Spray-On Skin exhibits potential for applications relating to healing of acute wounds

Avita Medical Ltd., the regenerative medicine company, announced today that a clinical study of 18 patients suffering from partial-thickness burns, some of which had failed to heal after treatment with other wound-healing methods ('chronic wounds'), demonstrated successful wound-healing after being treated with ReCell® Spray-On Skin™ from Avita Medical.

22 Apr 2011

Transplanting cells from healthy adult livers may help treat genetic liver-lung disorder

Transplanting cells from healthy adult livers may work in treating a genetic liver-lung disorder that affects millions of people worldwide, according to an animal study in the April 18 online edition of the Journal of Clinical Investigation.

22 Apr 2011

Viewpoints: Would Ryan plan save or 'assault' Medicare?; Controversial Kansas abortion law

Congressional Budget Office chief Doug Elmendorf dropped a bombshell on his Director's Blog this morning: federal spending on all health care programs will exceed $1 trillion this year. But when he turned to spelling out options for trimming that figure in the years ahead, he offered a limited and not very satisfying menu of choices, all of which involved doing less or charging people more.

21 Apr 2011

Researchers seek scientific evaluation for visual perception of adults with cleft lip, palate

The impact of physical attractiveness on social communication is a truth universally acknowledged. It is not surprising, therefore, that individuals with a cleft lip and palate have experienced social isolation and poor self-esteem.

16 Apr 2011

Study finds minimally invasive thyroid surgery effective in pediatric patients

Surgical approaches that reduce incision size and recovery time from thyroid surgery work well in children, physician-scientists report.

15 Apr 2011

Medisse completes FlexiSurge biomaterial study based on ISO standards

Medisse, a medical device company focused on the development of a new generation of resorbable flexible implants, announced today that it has successfully completed the biocompatibility evaluation of its novel resorbable FlexiSurge biomaterial in accordance with the international ISO 10993 standards.

12 Apr 2011

People with red eyes are considered sad, unhealthy and less attractive

Beauty is said to be in the eye of the beholder, but a new study reveals that the reverse is also true; unattractiveness is in the eye of the beheld. Research published in Ethology finds that people with bloodshot eyes are considered sadder, unhealthier and less attractive than people whose eye whites are untinted, a cue which is uniquely human.

8 Apr 2011

Kidney transplantion more effective than previously thought

A new study from Mayo Clinic, the largest long-term study of kidney transplant recipients published to date, demonstrates that progressive damage to kidney transplants may be less common and less severe than previously reported.

8 Apr 2011

La Jolla acquires GliaMed's novel class of compounds

La Jolla Pharmaceutical Company today announced that it has acquired the rights to a novel class of compounds known as Regenerative Immunophilin Ligands from privately held GliaMed, Inc.

5 Apr 2011

Master regulators of cholesterol and fat play key role in liver fibrosis development

UCLA researchers have demonstrated that a key regulator of cholesterol and fat metabolism in the liver also plays an important role in the development of liver fibrosis - the build-up of collagen scar tissue that can develop into cirrhosis. Cirrhosis, in turn, is a major cause of premature death and is incurable without a liver transplant.

31 Mar 2011

Improved technology is improving outcomes for cardiac stent patients

While coronary artery bypass surgery has long been the standard treatment for patients with the most extensive forms of coronary artery disease, the results of a recent study by an international team of researchers suggests that advances in technology appear to be narrowing the "benefit gap" between the two approaches. The results of the study appear in the March 17, 2011 issue of the New England Journal of Medicine.

28 Mar 2011

Tenascin-C protein can help promote wound healing

We all know the adage: A little bit of a good thing can go a long way. Now researchers in London are reporting that might also be true for a large protein associated with wound healing.

24 Mar 2011

Rxi's new RNAi preclinical data to be presented at Keystone conference

RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.

22 Mar 2011

Stem cell therapy can reduce heart size, scar tissue and improve function in cardiac patients

Researchers have shown for the first time that stem cells injected into enlarged hearts reduced heart size, reduced scar tissue and improved function to injured heart areas, according to a small trial published in Circulation Research: Journal of the American Heart Association.

18 Mar 2011

Stem cell therapy successfully heals a scarred and failing heart

A new study has shown that stem cells could heal scars caused by old heart attacks. In all eight patients who received the experimental treatment in an ongoing clinical trial this therapy worked. All of them had suffered heart attacks an average of 5 1/2 years prior; one of the patients had his heart attack 11 years earlier.

17 Mar 2011

XTIO2 presents XTI 360 ANTI-GERM SYSTEM to 83rd Academy Award-nominees

XTIO2 INC. (XTI) presented the 83rd Academy® Award-nominees with the XTI ANTI-GERM / ANTI-VOC / ANTI-ALLERGY SYSTEM, consisting of XTI 360™ Nanocoating and XTI™ Nano-Facemask. It is the world's most effective preventive measure and the best defense against germs transmitted via air and contact surfaces.

15 Mar 2011

BioSpecifics 2010 net loss decreases to $1.5 million

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2010.

11 Mar 2011

First hand transplant recipient on the way to recovery

A 26 year old mother has received the world’s first hand transplant. The 17 member surgical team from the Hand Transplant Program at Ronald Reagan UCLA Medical Center has performed the operation over 14 hours. They painstakingly attached tendons, blood vessels and nerves. The patient had lost her hand in a traffic accident 5 years ago. The patient is currently recovering.

8 Mar 2011

New advance in tissue engineering

Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center and colleagues reported today on a new advance in tissue engineering.

8 Mar 2011

First POSE procedure using USGI's Incisionless Operating Platform performed at Ospedale All'Angelo

USGI Medical, Inc. announced that a prominent surgeon in Italy performed the first POSE procedure on patients for weight loss.

8 Mar 2011

Scar News and Research

Avita's ReCell Spray-On Skin exhibits potential for applications relating to healing of acute wounds

Transplanting cells from healthy adult livers may help treat genetic liver-lung disorder

Viewpoints: Would Ryan plan save or 'assault' Medicare?; Controversial Kansas abortion law

Researchers seek scientific evaluation for visual perception of adults with cleft lip, palate

Study finds minimally invasive thyroid surgery effective in pediatric patients

Medisse completes FlexiSurge biomaterial study based on ISO standards

People with red eyes are considered sad, unhealthy and less attractive

Kidney transplantion more effective than previously thought

La Jolla acquires GliaMed's novel class of compounds

Master regulators of cholesterol and fat play key role in liver fibrosis development

Improved technology is improving outcomes for cardiac stent patients

Tenascin-C protein can help promote wound healing

Rxi's new RNAi preclinical data to be presented at Keystone conference

Stem cell therapy can reduce heart size, scar tissue and improve function in cardiac patients

Stem cell therapy successfully heals a scarred and failing heart

XTIO2 presents XTI 360 ANTI-GERM SYSTEM to 83rd Academy Award-nominees

BioSpecifics 2010 net loss decreases to $1.5 million

First hand transplant recipient on the way to recovery

New advance in tissue engineering

First POSE procedure using USGI's Incisionless Operating Platform performed at Ospedale All'Angelo

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News